Disease-specific anxiety symptomatology in Parkinson's disease

被引:34
|
作者
Dissanayaka, Nadeeka N. W. [1 ,2 ,3 ]
O'Sullivan, John D. [2 ,4 ]
Pachana, Nancy A. [3 ]
Marsh, Rodney [1 ,4 ,5 ]
Silburn, Peter A. [1 ,2 ,4 ]
White, Elizabeth X. [1 ,4 ]
Torbey, Elizabeth [1 ,3 ]
Mellick, George D. [1 ,2 ,6 ]
Copland, David A. [7 ]
Byrne, Gerard J. [1 ,3 ,4 ,5 ]
机构
[1] Univ Queensland, UQ Ctr Clin Res, Royal Brisbane & Womens Hosp, Bldg 71-918, Brisbane, Qld 4029, Australia
[2] Royal Brisbane & Womens Hosp, Dept Neurol, Neurol Res Ctr, Brisbane, Qld, Australia
[3] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia
[4] Univ Queensland, Royal Brisbane & Womens Hosp, Sch Med, Brisbane, Qld, Australia
[5] Royal Brisbane & Womens Hosp, Mental Hlth Serv, Brisbane, Qld, Australia
[6] Griffith Univ, Eskitis Inst Drug Discovery, Brisbane, Qld, Australia
[7] Univ Queensland, Sch Hlth & Rehabil Sci, Brisbane, Qld, Australia
关键词
anxiety; Parkinson's Disease; symptomatology; onset; RATING-SCALE; HOSPITAL ANXIETY; DISORDERS; DEPRESSION; PREVALENCE; VALIDATION; CRITERIA; ISSUES; RISK; MINI;
D O I
10.1017/S1041610215002410
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: Symptoms of anxiety relating to Parkinson's disease (PD) occur commonly and include symptomatology associated with motor disability and complications arising from PD medication. However, there have been relatively few attempts to profile such disease-specific anxiety symptoms in PD. Consequently, anxiety in PD is underdiagnosed and undertreated. The present study characterizes PD-related anxiety symptoms to assist with the more accurate assessment and treatment of anxiety in PD. Methods: Ninety non-demented PD patients underwent a semi-structured diagnostic assessment targeting anxiety symptoms using relevant sections of the Mini International Neuropsychiatric Interview (MINI-plus). In addition, they were assessed for the presence of 30 PD-related anxiety symptoms derived from the literature, the clinical experience of an expert panel and the PD Anxiety-Motor Complications Questionnaire (PDAMCQ). The onset of anxiety in relation to the diagnosis of PD was determined. Results: Frequent (>25%) PD-specific anxiety symptoms included distress, worry, fear, agitation, embarrassment, and social withdrawal due to motor symptoms and PD medication complications, and were experienced more commonly in patients meeting DSM-IV criteria for an anxiety disorder. The onset of common anxiety disorders was observed equally before and after a diagnosis of PD. Patients in a residual group of Anxiety Not Otherwise Specified had an onset of anxiety after a diagnosis of PD. Conclusion: Careful characterization of PD-specific anxiety symptomatology provides a basis for conceptualizing anxiety and assists with the development of a new PD-specific measure to accurately assess anxiety in PD.
引用
收藏
页码:1153 / 1163
页数:11
相关论文
共 50 条
  • [1] A disease-specific psychosocial questionnaire for Parkinson’s disease caregivers
    Noëlle G. A. Spliethoff-Kamminga
    Aeilko H. Zwinderman
    Machiel P. Springer
    Raymund A. C. Roos
    Journal of Neurology, 2003, 250 : 1162 - 1168
  • [2] A disease-specific psychosocial questionnaire for Parkinson's disease caregivers
    Spliethoff-Kamminga, NGA
    Zwinderman, AH
    Springer, MP
    Roos, RAC
    JOURNAL OF NEUROLOGY, 2003, 250 (10) : 1162 - 1168
  • [3] Psychosocial problems in Parkinson's disease: Evaluation of a disease-specific questionnaire
    Spliethoff-Kamminga, NGA
    Zwinderman, AH
    Springer, MP
    Roos, RAC
    MOVEMENT DISORDERS, 2003, 18 (05) : 503 - 509
  • [4] Effect of disease-specific complications on the prediction of utilities in Parkinson's disease
    Siebert, U
    Bornschein, B
    Spottke, EA
    Dodel, R
    VALUE IN HEALTH, 2004, 7 (06) : 794 - 794
  • [5] Network Analysis Identifies Disease-Specific Pathways for Parkinson’s Disease
    Chiara Monti
    Ilaria Colugnat
    Leonardo Lopiano
    Adriano Chiò
    Tiziana Alberio
    Molecular Neurobiology, 2018, 55 : 370 - 381
  • [6] Network Analysis Identifies Disease-Specific Pathways for Parkinson's Disease
    Monti, Chiara
    Colugnat, Ilaria
    Lopiano, Leonardo
    Chio, Adriano
    Alberio, Tiziana
    MOLECULAR NEUROBIOLOGY, 2018, 55 (01) : 370 - 381
  • [7] Parkinson's Disease-Specific Cortical Atrophy As An Independent Contributor To Motor Symptom In Parkinson's Disease
    Kang, S. W.
    Yoo, H. S.
    Lyoo, C. L.
    MOVEMENT DISORDERS, 2023, 38 : S103 - S103
  • [8] Novel disease-specific promoters for use in gene therapy for Parkinson's disease
    Wettergren, Erika Elgstrand
    Gussing, Fredrik
    Quintino, Luis
    Lundberg, Cecilia
    NEUROSCIENCE LETTERS, 2012, 530 (01) : 29 - 34
  • [9] Novel disease-specific promoters for use in gene therapy for Parkinson's disease
    Wettergren, E. Elgstrand
    Gussing, F.
    Jansson, E.
    Willassen, Y.
    Quintino, L.
    Lundberg, C.
    HUMAN GENE THERAPY, 2011, 22 (10) : A97 - A97
  • [10] Development of a Parkinson's Disease-Specific Admission Order Set
    Larson, D.
    Kianirad, Y.
    Afshari, M.
    Zadikoff, C.
    MOVEMENT DISORDERS, 2017, 32 (09) : E9 - E10